us en false false Default
Skip directly to Accessibility Notice
TRUH VanEck Healthcare TruSector ETF Please read important disclosure Close important disclosure Show More Show Less Compare false

TRUH
VanEck Healthcare TruSector ETF

TRUH
VanEck Healthcare TruSector ETF

  • NAV
    $32.91

    as of November 13, 2026
  • Performance since inception
    28.76%

    as of November 13, 2026
  • Total Net Assets
    $987.31K

    as of November 13, 2026
  • Total Expense Ratio
    0.10%
  • Inception Date
    04/01/2026

Overview

Why TRUH

  • Full Market Cap Sector ExposureProvides comprehensive market capitalization exposure to healthcare stocks unlike many traditional sector ETFs
  • Reduced Benchmark DeviationAvoids persistent underweighting of largest sector constituents that may cause performance drift
  • Precision Sector Allocation ToolDesigned to help asset allocators track sector benchmarks with greater accuracy

About TRUH

VanEck Healthcare TruSector ETF (the “Fund”) is an actively managed ETF that seeks long-term capital appreciation by investing in securities of healthcare-related companies or instruments that provide exposure to healthcare-related companies.

Performance

Average Annual Total Returns* (%)

  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
04/01/26
TRUH (NAV) 9.84 14.19 -- -- -- -- -- 26.09
TRUH (Market Price) 9.54 14.11 -- -- -- -- -- 26.11
MarketVector Top US Health Care Companies Index 9.99 14.17 -- -- -- -- -- 25.77
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
04/01/26
TRUH (NAV) -0.89 6.44 -- -- -- -- -- 14.79
TRUH (Market Price) -0.70 6.77 -- -- -- -- -- 15.13
MarketVector Top US Health Care Companies Index -0.91 6.17 -- -- -- -- -- 14.34

Holdings

Daily Holdings (%) as of 11/12/2026

Download XLS Get holdings
Total Holdings: 62
Ticker
Holding Name % of Net
Assets
Market Value
(US$)
LLY
Eli Lilly & Co 16.85 165,364
JNJ
Johnson & Johnson 10.05 98,665
ABBV
Abbvie Inc 7.65 75,085
MRK
Merck & Co Inc 5.33 52,314
UNH
Unitedhealth Group Inc 5.32 52,262
TMO
Thermo Fisher Scientific Inc 3.85 37,770
AMGN
Amgen Inc 3.71 36,431
GILD
Gilead Sciences Inc 3.06 30,063
ABT
Abbott Laboratories 2.73 26,813
PFE
Pfizer Inc 2.42 23,727
ISRG
Intuitive Surgical Inc 2.29 22,434
DHR
Danaher Corp 2.13 20,894
VRTX
Vertex Pharmaceuticals Inc 1.99 19,534
MDT
Medtronic Plc 1.90 18,683
BMY
Bristol-Myers Squibb Co 1.87 18,384
MCK
Mckesson Corp 1.87 18,310
CVS
Cvs Health Corp 1.69 16,611
SYK
Stryker Corp 1.62 15,932
ELV
Elevance Health Inc 1.36 13,327
REGN
Regeneron Pharmaceuticals Inc 1.36 13,317
MRNA
Moderna Inc 1.27 12,493
CI
Cigna Group/The 1.15 11,258
HCA
Hca Healthcare Inc 1.07 10,514
COR
Cencora Inc 0.96 9,415
BSX
Boston Scientific Corp 0.94 9,238
CAH
Cardinal Health Inc 0.94 9,179
EW
Edwards Lifesciences Corp 0.89 8,781
BDX
Becton Dickinson & Co 0.86 8,413
IDXX
Idexx Laboratories Inc 0.85 8,376
HUM
Humana Inc 0.81 7,986
A
Agilent Technologies Inc 0.72 7,093
IQV
Iqvia Holdings Inc 0.66 6,507
WAT
Waters Corp 0.66 6,471
VEEV
Veeva Systems Inc 0.65 6,351
GEHC
Ge Healthcare Technologies Inc 0.54 5,320
BIIB
Biogen Inc 0.54 5,260
MTD
Mettler-Toledo International Inc 0.53 5,193
RMD
Resmed Inc 0.51 5,017
CNC
Centene Corp 0.51 4,989
ZTS
Zoetis Inc 0.51 4,978
ILMN
Illumina Inc 0.47 4,610
LH
Labcorp Holdings Inc 0.46 4,468
DXCM
Dexcom Inc 0.45 4,395
DGX
Quest Diagnostics Inc 0.42 4,154
WST
West Pharmaceutical Services Inc 0.42 4,113
STE
Steris Plc 0.36 3,548
VTRS
Viatris Inc 0.35 3,411
INCY
Incyte Corp 0.30 2,921
ZBH
Zimmer Biomet Holdings Inc 0.29 2,823
RVTY
Revvity Inc 0.26 2,512
CRL
Charles River Laboratories Internationa 0.24 2,386
BAX
Baxter International Inc 0.20 1,931
SOLV
Solventum Corp 0.19 1,865
COO
Cooper Cos Inc/The 0.18 1,741
TECH
Bio-Techne Corp 0.17 1,673
ALGN
Align Technology Inc 0.15 1,503
PODD
Insulet Corp 0.15 1,493
UHS
Universal Health Services Inc 0.14 1,357
HSIC
Henry Schein Inc 0.12 1,206
DVA
Davita Inc 0.09 870
2602335D
Tpg Inc 0.00 0
-USD CASH-
-- -0.11 -1,116
--
Other/Cash 0.10 994
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Fees

Distributions

  as of  11/13/2026


Distribution Frequency

Quarterly


30-Day SEC Yield

1.31%


Distribution Yield

1.58%


12 Month Yield

--

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Healthcare TruSector ETF would have been 1.31% on 11/13/26. Distributions may vary from time to time.

Distribution History

Year Ex-date Record Date Payable date Dividend
Income‡
Short-Term
Capital Gains
Long-Term
Capital Gains
Return of
Capital
Total
Distributions
2026 10/01/2026 10/01/2026 10/06/2026 $ 0.1301 -- -- -- $ 0.13
2026 07/01/2026 07/01/2026 07/07/2026 $ 0.0847 -- -- -- $ 0.08

‡All registered investment companies are obliged to distribute portfolio gains to shareholders at yearend regardless of performance. Trading VanEck ETFs will also generate tax consequences and transaction expenses. The information provided is not intended to be tax advice. Tax consequences of dividend distributions may vary by individual taxpayer. There is no guarantee that dividends will be paid. To receive a distribution, you must have been a registered shareholder of the relevant VanEck ETFs on the record date. Distributions are paid to shareholders on the payment date. Past distributions are not indicative of future distributions.

Certain distributions may constitute a return of capital, which will have the effect of reducing your cost basis in the Fund’s shares and thereby increasing the amount of capital gain, if any, or decreasing the amount of capital loss, if any, that you will realize when selling or exchanging Fund shares. The final determination of the tax characteristics cannot be determined until after each Fund’s yearend and are reported to shareholders on Form 1099-DIV. The form is mailed to shareholders shortly after calendar yearend specifying how the distributions paid by the Fund during the prior calendar year should be characterized for purposes of reporting the distribution on a shareholder’s tax return.

The tax treatment and characterization of the Fund’s distributions may vary significantly from time to time depending on whether the Fund has gains or losses on the securities in its portfolio. The Fund’s distributions will normally reflect past and projected net investment income, and may include income from dividends and interest, capital gains and/or a return of capital. The final composition of the tax characteristics of the distributions cannot be determined with certainty until after the end of the year, and will be reported to shareholders at that time. The amount of distributions will vary, depending on a number of factors. As portfolio and market conditions change, the rate of dividends may change. There can be no assurance that the Fund will be able to declare a dividend distribution in each period. Past performance is no guarantee of future results.

Click here to access more detailed yearend tax information

Team

Resources

Regulatory Information

Thought Leadership

TRUH